Researchers from the Arizona Cancer Center and an international team of physicians and scientists have identified genetic markers between two types of lymphoma: Burkitt's Lymphoma and Diffuse Large B-Cell lymphoma.

The difference is critical because Burkitt's requires a much more intensive program of chemotheraphy than Diffuse Large B-Cell.

Pam White reports.

Related Web site Arizona Cancer Center